Tracking tuberculosis infection in new college students
Part of Infections clinical trials.
This study follows new college students with a strong reaction to a tuberculosis skin test to see if they develop the disease, and compares them to students without a strong reaction. It tests whether monitoring this group more closely can help catch tuberculosis early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a new college student between 14 and 24 years old.
- You have completed baseline tuberculosis screening including a chest X-ray and a tuberculin skin test.
- For the target group: your skin test reaction (induration) is at least 15 mm, or you had a severe local reaction like blisters or necrosis, and you were not diagnosed with active tuberculosis.
- For the control group: your skin test reaction is less than 15 mm (including negative, weakly positive, or moderately positive).
- If you are in the target group, you have not voluntarily received the Vaccae vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to best manage latent tuberculosis (TB) infection using a test that finds people at risk. It aims to help doctors and patients make better decisions together.
This study is collecting information from people who are starting TB treatment to learn more about how well the treatment works. The goal is to better understand factors that influence TB treatment success.
This trial tests a very short (one-month) medicine course to prevent tuberculosis (TB) in students and school staff who have been exposed to someone with active TB. If you have latent TB infection (the germs are in your body but you're not sick), this treatment aims to stop it from turning into active TB disease.
This study tests a program to find hidden (latent) tuberculosis infections in students who have been close to someone with active TB. It helps identify who might need treatment to prevent them from getting sick later.
This study follows people with suspected or confirmed tuberculosis (TB), whether they have inactive “latent” TB or active TB. It helps researchers better understand TB’s natural course and may improve future testing and care by allowing collection and storage of samples.
This study is looking at how a simple blood test can help monitor tuberculosis (TB) treatment. It may help doctors know sooner if the treatment is working.
Hear when a new Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.